CHRO (chromocell.com) Sof daromad

CHRO (Chromocell Therapeutics Corp.) - kompaniyaning tovar belgisi

Chromocell Therapeutics (CHRO) opioid bo'lmagan og'riq qoldiruvchi vositalarni ishlab chiqish uchun kimyoviy ta'minotni optimallashtirmoqda, bu esa kompaniyaning hozirda -0.01 miqdorida baholangan sof aktivlari bilan qo'llab-quvvatlanmoqda. Rahbariyat klinik sinovlar orqali surunkali og'riq terapiyasining tor segmentiga e'tibor qaratmoqda. Biznes hozirda rivojlanishining ilk bosqichlarida bo'lib, o'z naqd pul oqimi mavjud bo'lmagan holda, operatsion xarajatlarni qoplash uchun jalb qilingan kapitaldan foydalanmoqda.

CHRO (Chromocell) Kompaniyaning sof foydasi tarixi 21.02.2024dan 02.07.2025gacha

Chromocell Therapeutics Corp. (CHRO) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
Birja narxi Chromocell|CHRO - Tahlilchilar konsensus prognozi
- biznesning bozor baholash ko'rsatkichlari:
Bozor bahosi Chromocell|CHRO - Korxona qiymati
- kompaniyaning balans qiymati tafsilotlari:
Aksiyaning buxgalteriya qiymati Chromocell Therapeutics|CHRO - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati chromocell.com|CHRO - Kompaniyaning jami aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Chromocell Therapeutics|CHRO - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Chromocell Therapeutics Corp|CHRO - Kompaniya qarzlari|Balans qiymatiga qarzlar Chromocell|CHRO - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Chromocell Therapeutics|Shoshilinch likvidlik chromocell.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
CHRO - Kompaniyaning sof foydasi
Kompaniyaning asosiy tahlili:CHRO Chromocell
Chromocell Therapeutics Corporation brend mahsuloti

Yuqori sifatli emitentlarni tanlash erkin pul oqimlari tahliliga asoslangan bo'lib, bunda yakuniy moliyaviy natija biznesning qiymat yaratish qobiliyatini belgilaydi. Ushbu tendentsiya real daromadlarni aks ettiradi, ular Chromocell Therapeutics (CHRO) uchun og'riq terapiyasi nishasining patent monopolizatsiyasiga bevosita bog'liq bo'lib, bu kompaniyaning joriy foyda darajalari orqali ortiqcha foyda potentsialini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Kompaniyaning sof daromadi Biogen Idec (BIIB)|NBIX (Neurocrine Biosciences) - Sof foyda|Sof daromad regencellbioscience.com (RGC)|Sof foyda AXSM|ACAD (ACADIA Pharma) - Yakuniy foyda|Kompaniyaning sof foydasi Xenon Pharmaceuticals Inc XENE|Yakuniy foyda VKTX|SUPN - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi catalystpharma.com|Denali Therapeutics Inc. (DNLI) - Kompaniyaning sof foydasi|Sof daromad Harmony Biosciences Inc|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Kompaniyaning sof daromadi Amylyx Corp AMLX|Sof foyda TRVI|Sof daromad praxismedicines.com PRAX|Sof foyda AVXL (Anavex Life Sciences Corp.)|CeriBell Inc (CBLL) - Kompaniyaning sof daromadi|PRTA - Kompaniyaning sof foydasi|ALEC: Kompaniyaning sof foydasi|Annexon, Inc. (ANNX) - Kompaniyaning sof foydasi|OMER (Omeros) - Kompaniyaning sof foydasi|Sof daromad NGNE|ACIU: Yakuniy foyda|Sof daromad VYGR (Voyager Pharma)|Soliqlar to‘langandan keyingi foyda NMRA|Sof foyda SCLX (Scilex Holding Company)|Yakuniy foyda TVGN|Alpha Cognition Corp - Sof foyda|Kompaniyaning sof daromadi cogrx.com|Inhibikase (IKT) - Kompaniyaning sof foydasi|Cassava Pharma - Yakuniy foyda|ASRT (Assertio Holdings) - Sof foyda|Sof foyda Coya|Kompaniyaning sof foydasi Vistagen Therapeutics (VTGN)|OVID: Soliqdan keyingi foyda|Sof foyda ABOS (Acumen Pharma)|CervoMed Corporation (CRVO) - Kompaniyaning sof daromadi|ATHE: Sof daromad|CLNN - Sof foyda|PEPG (pepgen.com) - Sof daromad|JUNS: Soliqlar to‘langandan keyingi foyda|RLMD (Relmada) - Sof foyda|Annovis Bio Corporation (ANVS) - Sof moliyaviy natija|Sof foyda GRCE|Sof daromad fireflyneuro.com AIFF|Kompaniyaning sof foydasi Klotho Neurosciences KLTO|Sof moliyaviy natija NeuroSense Therapeutics Ltd (NRSN)|Reviva Pharmaceuticals Holdings - Sof foyda|MetaVia Inc (MTVA) - Sof daromad|NRXS: Sof foyda|Helius Medical Technologies - Yakuniy foyda|Kompaniyaning sof foydasi Passage Bio Inc.|NEUP: Yakuniy foyda|Kompaniyaning sof foydasi Minerva Neurosciences Corp (NERV)|ATHA - Kompaniyaning sof daromadi|Kompaniyaning sof foydasi Addex Therapeutics ADXN|ALZN: Kompaniya foydasi|Cyclerion - Sof foyda|Kompaniyaning sof daromadi Protagenic Therapeutics|KTTA (pasitheaclinics.com) - Sof daromad|Cortigent (CRGT) - Sof foyda|Kompaniyaning sof foydasi Avenue Therapeutics|BCLI: Yakuniy foyda|Kompaniyaning sof foydasi Cara Therapeutics (CARA)|ELYM - Kompaniyaning sof daromadi|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|LBPH - Sof daromad|Marinus Pharmaceuticals - Sof foyda|Yakuniy foyda NKGN (nkgenbiotech.com)|NeuroBo Pharmaceuticals, Inc. (NRBO) - Kompaniyaning sof foydasi|Sage Therapeutics Inc. - Yakuniy foyda|Kompaniyaning sof foydasi Neurotrope|Kompaniyaning sof daromadi Trevena Inc TRVN|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|Sof daromad Anew Medical Inc. WENA|Kompaniyaning sof foydasi Cerevel Therapeutics, Inc. CERE